FR2421912A1 - Derives d'acide thio-etianique, leur procede de production et medicament les contenant - Google Patents

Derives d'acide thio-etianique, leur procede de production et medicament les contenant

Info

Publication number
FR2421912A1
FR2421912A1 FR7907823A FR7907823A FR2421912A1 FR 2421912 A1 FR2421912 A1 FR 2421912A1 FR 7907823 A FR7907823 A FR 7907823A FR 7907823 A FR7907823 A FR 7907823A FR 2421912 A1 FR2421912 A1 FR 2421912A1
Authority
FR
France
Prior art keywords
radical
alpha
beta
chloro
thio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7907823A
Other languages
English (en)
Other versions
FR2421912B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2421912A1 publication Critical patent/FR2421912A1/fr
Application granted granted Critical
Publication of FR2421912B1 publication Critical patent/FR2421912B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention a trait au domaine de la chimie médicale. Elle concerne certains esters d'acides 3-oxoandrost-4-ène et 3-oxoandrosta-1,4-diène- 17 beta -thiocarboxyliques. Ces composés sont éventuellement substitués en position 6 alpha avec un radical fluoro ou chloro; en position 9 alpha avec un radical fluoro, chloro ou bromo; en position 11 avec un radical céto, un radical beta -hydroxy ou un radical beta -chloro (ce dernier seulement lorsqu'il y a un radical chloro en position 9 alpha ; en positions 16 alpha et 17 alpha avec un radical isopropylidènedioxy; et en position 16 alpha (ou 16 beta ) avec un radical méthyle ou un atome d'hydrogène lorsqu'il y a un groupe hydroxy ou un ester en position 17 alpha . Les composés de l'invention sont des stéroïdes anti-inflammatoires.
FR7907823A 1978-04-05 1979-03-28 Derives d'acide thio-etianique, leur procede de production et medicament les contenant Granted FR2421912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/893,388 US4188385A (en) 1978-04-05 1978-04-05 Thioetianic acid derivatives

Publications (2)

Publication Number Publication Date
FR2421912A1 true FR2421912A1 (fr) 1979-11-02
FR2421912B1 FR2421912B1 (fr) 1981-03-20

Family

ID=25401484

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7907823A Granted FR2421912A1 (fr) 1978-04-05 1979-03-28 Derives d'acide thio-etianique, leur procede de production et medicament les contenant

Country Status (28)

Country Link
US (1) US4188385A (fr)
EP (1) EP0004741B1 (fr)
JP (2) JPS54141758A (fr)
AR (1) AR226035A1 (fr)
AT (1) AT368168B (fr)
AU (1) AU526025B2 (fr)
CA (1) CA1134345A (fr)
CS (1) CS203956B2 (fr)
DE (2) DE2960096D1 (fr)
DK (1) DK147735C (fr)
ES (1) ES479271A1 (fr)
FI (1) FI66393C (fr)
FR (1) FR2421912A1 (fr)
GB (1) GB2018256B (fr)
GR (1) GR67275B (fr)
HK (1) HK41284A (fr)
HU (1) HU179314B (fr)
IL (1) IL56972A0 (fr)
IT (1) IT1120954B (fr)
MY (1) MY8500575A (fr)
NO (1) NO152935C (fr)
NZ (1) NZ190076A (fr)
PL (1) PL121469B1 (fr)
PT (1) PT69409A (fr)
SG (1) SG6786G (fr)
SU (1) SU1052161A3 (fr)
YU (1) YU40929B (fr)
ZA (1) ZA791635B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4310466A (en) * 1979-08-31 1982-01-12 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
FR2477156A1 (fr) * 1980-02-15 1981-09-04 Glaxo Group Ltd Carbothioates d'androstanes, leur procede de preparation, composes pour leur preparation et leur application en therapeutique
JPS56138200A (en) * 1980-02-15 1981-10-28 Glaxo Group Ltd Androstane carbothioate compound
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
GB9225923D0 (en) * 1992-12-11 1993-02-03 Rhone Poulenc Rorer Ltd New compositions of matter
HUT72442A (en) * 1992-12-24 1996-04-29 Rhone Poulenc Rorer Ltd Steroids condensed with heteroring containing oxygene, pharmaceutical compositions containing them and processes for their production
BR9612309A (pt) * 1995-12-29 1999-07-13 Glaxo Group Ltd Composto uso de um composto composição farmacêutica formulação farmacêutica de aerossol combinação e processos para o tratamento de um indivíduo humano ou animal com uma condição anti-inflamatória e/ou alérgica e para a preparação de um composto
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
OA12394A (en) * 2000-08-05 2004-07-09 Glaxo Group Ltd 6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent.
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
EP2039700A2 (fr) * 2001-04-30 2009-03-25 Glaxo Group Limited Nouveaux dérivés androstènes anti-inflammatoires
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
CA2530680A1 (fr) * 2003-04-04 2004-10-14 Alpharma Aps Methode de preparation de derives et d'intermediaires d'acides carbothioiques steroides
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
US8524697B2 (en) * 2007-12-21 2013-09-03 Merck Sharp & Dohme Corp. C20-C21 substituted glucocorticoid receptor agonists
AR077101A1 (es) 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2509171A (en) * 1946-02-06 1950-05-23 Ciba Ltd Primary alcohols from thiocarboxylic acids and esters
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US3989686A (en) * 1972-06-15 1976-11-02 Glaxo Laboratories Limited Anaesthetic steroids of the androstane series and process for preparing same
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.

Also Published As

Publication number Publication date
SG6786G (en) 1986-08-01
GB2018256B (en) 1983-02-02
SU1052161A3 (ru) 1983-10-30
CA1134345A (fr) 1982-10-26
JPS6140648B2 (fr) 1986-09-10
DE2912331A1 (de) 1979-10-18
CS203956B2 (en) 1981-03-31
DE2960096D1 (en) 1981-03-19
YU40929B (en) 1986-08-31
AU526025B2 (en) 1982-12-16
AT368168B (de) 1982-09-27
GR67275B (fr) 1981-06-26
FI791081A (fi) 1979-10-06
ATA251979A (de) 1982-01-15
NO152935B (no) 1985-09-09
HK41284A (en) 1984-05-18
GB2018256A (en) 1979-10-17
EP0004741A2 (fr) 1979-10-17
YU80379A (en) 1983-04-30
DK147735B (da) 1984-11-26
JPS54141758A (en) 1979-11-05
AU4558379A (en) 1979-10-18
PL214676A1 (fr) 1980-01-02
IL56972A0 (en) 1979-05-31
PL121469B1 (en) 1982-05-31
JPS6069019A (ja) 1985-04-19
JPS611038B2 (fr) 1986-01-13
IT7967652A0 (it) 1979-03-28
NO152935C (no) 1985-12-18
PT69409A (en) 1979-04-01
NO791140L (no) 1979-10-08
NZ190076A (en) 1984-07-31
US4188385A (en) 1980-02-12
FR2421912B1 (fr) 1981-03-20
EP0004741B1 (fr) 1981-01-28
FI66393B (fi) 1984-06-29
DK147735C (da) 1985-08-19
HU179314B (en) 1982-09-28
DK136579A (da) 1979-10-06
EP0004741A3 (en) 1979-11-14
ES479271A1 (es) 1980-01-16
AR226035A1 (es) 1982-05-31
FI66393C (fi) 1984-10-10
MY8500575A (en) 1985-12-31
ZA791635B (en) 1980-11-26
IT1120954B (it) 1986-03-26

Similar Documents

Publication Publication Date Title
FR2421912A1 (fr) Derives d'acide thio-etianique, leur procede de production et medicament les contenant
FR2437396B1 (fr) Derives d'acide carboxylique d'alcanol monoamines tertiaires
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
ES2058561T3 (es) Esteroides sustituidos con acido fosfonico como inhibidores de la esteroide-5alfa-reductasa.
ATE90355T1 (de) Weiche steroide mit anti-entzuendungswirkung.
HU183000B (en) Process for preparing corticoid-21-sulphopropionates and salts thereof with pharmaceutical activity
EP0133935B1 (fr) Dérivés d'acides p-oxybenzoiques, procédés pour leur préparation et leur utilisation pour la préparation de médicaments ayant une activité hypolipémique
FR2429019A1 (fr) Medicaments contenant des esters de 1-b-d-arabinofuranosylcytosine-5'-phosphate
DE3776572D1 (de) 14,17-g(b)-ethano-14-g(b)-estratriene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
US4648995A (en) Chemical synthesis
KR870006081A (ko) 신규 16,17-아세탈치환 프레그난 21-오익 에시드유도체 및 그의 제조방법
FR2444686A1 (fr) Procede pour la synthese de steroides
MA20388A1 (fr) Procede de preparation d'une nouvelle composition constitueed'une part ,a titre de principe actif par la 9 alpha,11beta-dichloro 16alpha-methyl21-oxycarbonyl dicycloxyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part excipient pharmaceutique inerte apte a permettre l'action du produit ........
EP0036652A3 (fr) Dérivés de céphalosporine, leur préparation, leurs compositions, leur utilisation dans le traitement contre des maladies et leurs intermédiaires
GB814000A (en) Steroid compounds and the preparation thereof
GB1075407A (en) Androstan-1ª‡,3ª‡,17ª‰-triol and its esters and a process for their manufacture
DE2543775A1 (de) Ester von analoga des pge tief 2 , deren 15-epimere und racemische formen, verfahren zur herstellung derselben sowie arzneimittel
FR2429781A1 (fr) Esters d'acides dihalogenevinyl-cyclopropane-thioliques, procede pour leur preparation et leur application dans la lutte anti-parasitaire
ATE13676T1 (de) Delta-1,3,5-3-chlor-11-beta,16-alpha,17-alpha,2 - tetra-(hydroxy)-pregnan-20-on-16,17acetonidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE1668859B1 (de) 6alpha,9alpha-Difluorhydrocortison-bzw.prednilon-17-valerat
JPS5481255A (en) Steroid derivative
Cope Principles of modern steroid therapy: part I
FR2372799A1 (fr) Derives d'esters de l'acide isovalerique, leur procede de preparation et insecticides contenant ces derives
DE843411C (de) Verfahren zur Gewinnung in 21-Stellung substituierter Pregnanderivate

Legal Events

Date Code Title Description
ST Notification of lapse